Adamis Pharma submits U.S. marketing application for naloxone prefilled syringe

Adamis Pharmaceuticals (NASDAQ:ADMP) is up 1% after hours following its announcement that it has filed a U.S. marketing application seeking approval for a single-dose prefilled syringe formulation of opioid overdose agent naloxone.

https://seekingalpha.com/news/3419807-adamis-pharma-submits-u-s-marketing-application-naloxone-prefilled-syringe-shares-1-percent